CClinicalTrials.gg
Active, not recruitingNCT04738409Updated Dec 8, 2023

Ovarian Hyperandrogenism in Normal and Excessive Body Weight Adolescent Girls and Their Relation to Diet (HAstudy)

An interventional study of Lifestyle intervention and Effects of AIDiet intervention to improve diet quality, immuno-metabolic health in normal and overweight PCOS girls in Polycystic Ovary Syndrome, sponsored by Poznan University of Physical Education. Active, not recruiting at 2 sites in Poland. Open to female participants aged 13 Years to 18 Years. Per ClinicalTrials.gov, last updated 2023-12-08.

Sponsored by Poznan University of Physical Education · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Non-randomized
Ages
13 Years to 18 Years
Sex
Female
01

Study summary

The objective was

  1. to check whether serum androgen levels and concomitant metabolic changes, oxidative stress and inflammation in adolescent girls with hyperandrogenism may be related to diet.
  2. to identify the factors that increase the risk of being overweight and of obesity among adolescents with clinical features of PCOS, related to diet and DEA (Disordered Eating Attitudes)
  3. to investigate the relationships between markers of oxidation and markers of Systemic Inflammation and macronutrients intake
  4. to assess the relation between oral health of girls with PCOS (including condition of periodontium and dental caries) and their dietary habits, hormonal, metabolic and oxidative and inflammatory status.
Read the detailed description

Hyperandrogenism in women is a state of increased androgen production, manifested by irregular menstrual cycles, a more frequent incidence of infertility, metabolic syndrome, oxidative stress, and inflammation, as well as acne and hirsutism. In addition to ovulation disorders and the multifollicular ovaries structure in an ultrasound examination, hyperandrogenism is a typical clinical feature of the Polycystic Ovary Syndrome (PCOS), which is diagnosed in approximately 8.6% of adolescent girls. Excessive body weight makes it difficult to diagnose at an early stage of the disease and intensifies metabolic and hormonal disorders, as well as those related to oxidative stress and inflammation of the body. Some research studies suggest that PCOS may negatively affect oral health of women, increasing the risk of periodontal problems.

The main purpose of this research was to check whether serum androgen levels and concomitant metabolic changes, oxidative stress and inflammation in adolescent girls with hyperandrogenism may be related to diet.

The investigators aimed to identify the factors that increase the risk of being overweight and of obesity among adolescents with clinical features of PCOS, related to diet and DEA(Disordered Eating Attitudes).

The objective was also to investigate the relationships between markers of oxidation and markers of Systemic Inflammation and macronutrients intake, such as carbohydrates and fiber, protein (animal, plant), fats and cholesterol in normal and overweight/obese girls with clinical features of PCOS.

Additionally, the investigators would like to evaluate the relation between oral health of girls with PCOS (including condition of periodontium and dental caries) and their dietary habits, hormonal, metabolic and oxidative and inflammatory status.

02

Conditions studied

  • Polycystic Ovary Syndrome
03

Who can participate

Ages eligible
13 Years to 18 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

The criteria for the patient's inclusion were based on the 2003 Rotterdam criteria, with the presence of at least two of the following:

  • written consent for inclusion (girls and their parents)
  • clinical and/or biochemical hyperandrogenism (hirsutism with moderate to severe acne, and/or elevation of serum total testosterone or free testosterone,
  • oligoovulation (based on oligomenorrhea defined as bleeding episodes occurring less than 8 times per year or secondary amenorrhea),
  • polycystic ovarian picture in an ultrasound examination (at least 12 follicles in each ovary each measuring 2-9 mm in diameter and/or ovarian volume >10 mL).

Exclusion criteria

Exclusion Criteria:

  • any systemic disease, thyroid dysfunction, diabetes, congenital adrenal hyperplasia, Cushing syndrome, hyperprolactinemia suggestive of pituitary adenoma and androgen-secreting tumors
  • medications of continuous use,
  • the use of hormonal therapy or antibiotics in the past three months,
  • vitamin or supplements use,
  • alcohol consumption
  • smoking
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
200 participants (actual)

Study arms

  • Experimental
    Ov/Ob group

    PCOS subjects (Overweight/Obesity)

    Other: Lifestyle intervention · Other: Effects of AIDiet intervention to improve diet quality, immuno-metabolic health in normal and overweight PCOS girls

  • Experimental
    N group

    PCOS subjects (Normal weight)

    Other: Lifestyle intervention · Other: Effects of AIDiet intervention to improve diet quality, immuno-metabolic health in normal and overweight PCOS girls

  • No intervention
    H group

    Healthy control subjects

Interventions

  • OtherLifestyle intervention

    The purpose of the research is to evaluate the potential of a multidimensional lifestyle program for PCOS girls. The primary aim is to verify the effectiveness of a 16-week AID intervention vs. HCD (combined with PA\&T), in terms of improvement in androgens level and immune-metabolic risk parameters

  • OtherEffects of AIDiet intervention to improve diet quality, immuno-metabolic health in normal and overweight PCOS girls

    The purpose of the intervention is to evaluate the effectiveness of the anti-inflammatory diet (AIDiet) among normal weight (N) and overweight/obese (Ov/Ob) women with PCOS.

05

What researchers measure

Primary outcomes

  1. Blood parameters

    Hormonal and biochemical parameters, including follicle-stimulating hormone (FSH), luteinizing hormone (LH), total testosterone, androstenedione, estradiol, dehydroepiandrosterone (DHEA-S), Sex Hormone Binding Globulin (SHBG), fasting glucose and fasting insulin, total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), and triglycerides (TG), 17 OH-Progesterone, Prolactin, Cortisol, Thyroid-stimulating hormone (TSH), will be measured in the morning after overnight fasting.

    Time frame: 2018-2022

  2. Anthropometric Assessment

    Body mass index BMI: derived from measured body height (m) and body weight (kg) as body weight / height². Weight will be measured to the nearest 0.1 kg using digital medical scales. Height will be measured with a stadiometer attached to the scales. Waist circumference (WC) will be measured to the nearest 0.1 mm using anthropometric tape between the lower border of rib margin and the upper border of iliac crest (WC-mid).

    Time frame: 2018-2022

  3. Body Composition

    Body composition will be assessed with a body composition analyzer (BIA method). The measurements of fat mass (FM) will be expressed as a percentage (%) and kilograms (kg).

    Time frame: 2018-2022

Other outcomes

  1. Disordered Eating Attitudes

    Eating behavior will be assessed with a standard Eating Attitudes Test-26 (EAT-26), a self-administrated questionnaire.

    Time frame: 2018-2022

  2. Inflammation and Oxidative Stress

    Serum concentrations of the inflammation markers: Interleukin 1 (IL-1), Interleukin 6 (IL-1), Tumor Necrosis Factor (TNF-α), C-reactive protein (CRP) and the markers of oxidation: malondialdehyde, total antioxidant capacity will be measured with a commercial ELISA assay kits

    Time frame: 2018-2022

  3. Nutrition evaluation

    Nutrition evaluation will be conducted by continuous recording of all consumed foodstuffs, dishes and beverages, specifying home measures and weight (3-day food record method and food frequency method FFQ). Data will be analysed using The Aliant computer program (Cambridge Diagnostics).

    Time frame: 2018-2022

  4. Oral Health Assessment

    * Severity of gingivitis expressed as a Gingival Index (GI) * Presence of gingivitis assessed based on the percentage of sites bleeding upon probing BOP%. * The subgingival microflora assessed on the basis of the number of specific bacteria isolated from gingival sulci of every individual and the percentage of patients affected by specific periodontal pathogens. * Salivary levels of TNF-alfa, IL-6, IL-1B, uric acid used to assess and compare the inflammation in oral environment. * Testosteron in saliva used to compare androgenic status of patients with PCOS and healthy controls.

    Time frame: 2018-2022

  5. Evaluation of physical activity

    International Physical Activity Questionnaire will be applied, including records of the type and specific character of the training and activity, its duration, intensity and frequency.

    Time frame: 2018-2022

  6. The Data From The Child's Health Book

    Collected from the child's health book regarding newborn body weight and term of delivery. The incidence of macrosomia (body weight over 4000 g) or low birth weight, LBW (body weight less than 2500 g) was assessed on the basis of the newborn's body weight. The full term of delivery (term births) will be assessed for deliveries that occur between 38-42 weeks of pregnancy, while preterm births will be defined as those deliveries between 23 weeks and 37 weeks

    Time frame: 2018-2022

06

Study locations

2 sites
  • Poznan University of Medical Sciences
    Poznan, 61-701, Poland
  • Poznan University of Physical Education
    Poznan, 61-871, Poland
07

References and documents

Publications

  • Mizgier M, Watrowski R, Opydo-Szymaczek J, Jodlowska-Siewert E, Lombardi G, Kedzia W, Jarzabek-Bielecka G. Association of Macronutrients Composition, Physical Activity and Serum Androgen Concentration in Young Women with Polycystic Ovary Syndrome. Nutrients. 2021 Dec 24;14(1):73. doi: 10.3390/nu14010073. PubMed 35010948 ↗
  • Mizgier M, Jarzabek-Bielecka G, Formanowicz D, Jodlowska-Siewert E, Mruczyk K, Cisek-Wozniak A, Kedzia W, Opydo-Szymaczek J. Dietary and Physical Activity Habits in Adolescent Girls with Polycystic Ovary Syndrome (PCOS)-HAstudy. J Clin Med. 2021 Aug 5;10(16):3469. doi: 10.3390/jcm10163469. PubMed 34441766 ↗
  • Mizgier M, Jarzabek-Bielecka G, Wendland N, Jodlowska-Siewert E, Nowicki M, Brozek A, Kedzia W, Formanowicz D, Opydo-Szymaczek J. Relation between Inflammation, Oxidative Stress, and Macronutrient Intakes in Normal and Excessive Body Weight Adolescent Girls with Clinical Features of Polycystic Ovary Syndrome. Nutrients. 2021 Mar 10;13(3):896. doi: 10.3390/nu13030896. PubMed 33801995 ↗

Study documents

  • Study protocol · Jan 28, 2021

Documents are hosted by the registry — open the source record to download them.

08

Registry details

Key details

Study ID
NCT04738409
Lead sponsor
Poznan University of Physical Education
Collaborators
National Science Centre, Poland, Poznan University of Medical Sciences
Responsible party
Małgorzata Mizgier (Assistant Professor, Poznan University of Physical Education) — Principal investigator
First posted
Feb 4, 2021
Start date
Apr 1, 2018
Primary completion
Sep 1, 2020
Completion
Dec 31, 2025 (estimated)
Last update
Dec 8, 2023

Study contacts

Małgorzata Mizgier, PhD
principal investigator · Poznan University of Phisical Education, Dietetic Department
Justyna Opydo-Szymaczek, PhD
principal investigator · Poznan University of Medical Scienses
Grażyna Jarząbek-Bielecka, PhD
principal investigator · Poznan University of Medical Scienses

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Dec 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion